[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Drug Abuse Testing Market Size study, by Product & Services (Analyzers, Rapid Testing Devices, Consumables, and Laboratory Services), By Sample Type (Urine, Oral Fluid, Breath, Hair, and Others), By End-User (Workplaces & Schools, Criminal Justice Systems & Law Enforcement Agencies, Research Laboratories, and Hospitals), and Regional Forecasts 2020-2027

July 2020 | 200 pages | ID: G4EF1E80DCA3EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Drug Abuse Testing Market is valued approximately at USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2027. Clinical procedures for drug testing monitoring have undergone significant improvements in the past five years to remain abreast of the rapid increase of emerging drugs that are being exploited, substitute matrices, and consumer demands. Drug addiction monitoring is a non-invasive scientific examination of biological materials, such as saliva, clothing, semen, and others, to detect the existence of illicit, addictive medications or their metabolites. Of such urine samples were the most favored form of examination used for drug abuse testing. Drug monitoring is a vital add-on to health treatment and drug usage. Drug monitoring is commonly being utilized for sporting clubs, businesses, medical uses, and a variety of other applications. The rise in the number of individuals who drink alcohol and illegal substances, such as tobacco, methamphetamine and others, is one of the key causes of the need for substance addiction treatment. In addition, technological advances in drug screening / testing devices and strict government regulations requiring drug screening are boosting market growth. However, the lack of understanding and recognition regarding substance monitoring as a violation of privacy rights in certain countries limits the expansion of the global demand for opioid addiction research. Emerging markets, such as Asia-Pacific and LAMEA, provide lucrative market growth opportunities for drug abuse testing. Moreover, Testing has become mandatory for multiple national and international organizations such as the International Olympic Committee (IOC), the International Sports Federation (ISF) and the National Olympic Committee to stop drug abuse in sport. As a consequence, the market is expected to expand at a steady pace during the forecast period (2020-2027). Moreover, the rising pattern observed in the industry for drug abuse testing is that leading players are expanding their product range by incorporating goods and upgrading applications with different drug abuse testing substances in order to retain their expertise and market share. For instance, Thermo Fisher Science obtained 510 (k) approval from the U.S. in August 2016. FDA for the DRI Hydrocodone Assay. Such test allows the identification of hydrocodone, the most commonly administered and misused opiate drug in the U.S.
The regional analysis of global Drug Abuse Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is expected to lead the regional demand for substance addiction treatment. Growth is mostly attributed due to the growing usage of illegal narcotics in the area. To reduce drug abuse cases, the U.S. government has taken several initiatives, including mandatory drug testing in multiple departments, including defense, oil and gas, mining, and the Department of Transportation (DOT). Drug testing has also been made compulsory in educational institutions.
Major market player included in this report are:
Drдgerwerk AG & Co. KGaA
Abbott Laboratories
F. Hoffmann-La Roche AG
Bio-Rad Laboratories, Inc.
Siemens AG
Thermo Fisher Scientific, Inc.
Danaher Corporation
Quest Diagnostics Incorporated
Express Diagnostics International Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Services:
Analyzers
Rapid Testing Devices
Consumables
Laboratory Services
By Sample Type:
Urine
Oral Fluid
Breath
Hair
Others
By End-User:
Workplaces & Schools
Criminal Justice Systems & Law Enforcement Agencies
Research Laboratories
Hospitals
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Drug Abuse Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
  1.2.1. Drug Abuse Testing Market, by Region, 2018-2027 (USD Billion)
  1.2.2. Drug Abuse Testing Market, by Product & Services, 2018-2027 (USD Billion)
  1.2.3. Drug Abuse Testing Market, by Sample Type, 2018-2027 (USD Billion)
  1.2.4. Drug Abuse Testing Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL DRUG ABUSE TESTING MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL DRUG ABUSE TESTING MARKET DYNAMICS

3.1. Drug Abuse Testing Market Impact Analysis (2018-2027)
  3.1.1. Market Drivers
  3.1.2. Market Challenges
  3.1.3. Market Opportunities

CHAPTER 4. GLOBAL DRUG ABUSE TESTING MARKET: INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICES

5.1. Market Snapshot
5.2. Global Drug Abuse Testing Market by Product & Services, Performance - Potential Analysis
5.3. Global Drug Abuse Testing Market Estimates & Forecasts by Product & Services 2017-2027 (USD Billion)
5.4. Drug Abuse Testing Market, Sub Segment Analysis
  5.4.1. Analysers
  5.4.2. Rapid Testing Devices
  5.4.3. Consumables
  5.4.4. Laboratory Services

CHAPTER 6. GLOBAL DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE

6.1. Market Snapshot
6.2. Global Drug Abuse Testing Market by Sample Type, Performance - Potential Analysis
6.3. Global Drug Abuse Testing Market Estimates & Forecasts by Sample Type 2017-2027 (USD Billion)
6.4. Drug Abuse Testing Market, Sub Segment Analysis
  6.4.1. Urine
  6.4.2. Oral Fluid
  6.4.3. Breath
  6.4.4. Hair
  6.4.5. Others

CHAPTER 7. GLOBAL DRUG ABUSE TESTING MARKET, BY END-USE

7.1. Market Snapshot
7.2. Global Drug Abuse Testing Market by End-Use, Performance - Potential Analysis
7.3. Global Drug Abuse Testing Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)
7.4. Drug Abuse Testing Market, Sub Segment Analysis
  7.4.1. Workplaces & Schools
  7.4.2. Criminal Justice Systems & Law Enforcement Agencies
  7.4.3. Research Laboratories
  7.4.4. Hospitals

CHAPTER 8. GLOBAL DRUG ABUSE TESTING MARKET, REGIONAL ANALYSIS

8.1. Drug Abuse Testing Market, Regional Market Snapshot
8.2. North America Drug Abuse Testing Market
  8.2.1. U.S. Drug Abuse Testing Market
    8.2.1.1. Product & Services breakdown estimates & forecasts, 2017-2027
    8.2.1.2. Sample Type breakdown estimates & forecasts, 2017-2027
    8.2.1.3. End-Use breakdown estimates & forecasts, 2017-2027
  8.2.2. Canada Drug Abuse Testing Market
8.3. Europe Drug Abuse Testing Market Snapshot
  8.3.1. U.K. Drug Abuse Testing Market
  8.3.2. Germany Drug Abuse Testing Market
  8.3.3. France Drug Abuse Testing Market
  8.3.4. Spain Drug Abuse Testing Market
  8.3.5. Italy Drug Abuse Testing Market
  8.3.6. Rest of Europe Drug Abuse Testing Market
8.4. Asia-Pacific Drug Abuse Testing Market Snapshot
  8.4.1. China Drug Abuse Testing Market
  8.4.2. India Drug Abuse Testing Market
  8.4.3. Japan Drug Abuse Testing Market
  8.4.4. Australia Drug Abuse Testing Market
  8.4.5. South Korea Drug Abuse Testing Market
  8.4.6. Rest of Asia Pacific Drug Abuse Testing Market
8.5. Latin America Drug Abuse Testing Market Snapshot
  8.5.1. Brazil Drug Abuse Testing Market
  8.5.2. Mexico Drug Abuse Testing Market
8.6. Rest of The World Drug Abuse Testing Market

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Top Market Strategies
9.2. Company Profiles
  9.2.1. Drдgerwerk AG & Co. KGaA
    9.2.1.1. Key Information
    9.2.1.2. Overview
    9.2.1.3. Financial (Subject to Data Availability)
    9.2.1.4. Industry Summary
    9.2.1.5. Recent Developments
  9.2.2. Abbott Laboratories
  9.2.3. F. Hoffmann-La Roche AG
  9.2.4. Bio-Rad Laboratories, Inc.
  9.2.5. Siemens AG
  9.2.6. Thermo Fisher Scientific, Inc.
  9.2.7. Danaher Corporation
  9.2.8. Quest Diagnostics Incorporated
  9.2.9. Express Diagnostics International Inc.

CHAPTER 10. RESEARCH PROCESS

10.1. Research Process
  10.1.1. Data Mining
  10.1.2. Analysis
  10.1.3. Market Estimation
  10.1.4. Validation
  10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. GLOBAL DRUG ABUSE TESTING MARKET, REPORT SCOPE
TABLE 2. GLOBAL DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
TABLE 3. GLOBAL DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY PRODUCT & SERVICES 2017-2027 (USD BILLION)
TABLE 4. GLOBAL DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SAMPLE TYPE 2017-2027 (USD BILLION)
TABLE 5. GLOBAL DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY END-USE 2017-2027 (USD BILLION)
TABLE 6. GLOBAL DRUG ABUSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 7. GLOBAL DRUG ABUSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 8. GLOBAL DRUG ABUSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 9. GLOBAL DRUG ABUSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 10. GLOBAL DRUG ABUSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 11. GLOBAL DRUG ABUSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 12. GLOBAL DRUG ABUSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 13. GLOBAL DRUG ABUSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 14. GLOBAL DRUG ABUSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 15. GLOBAL DRUG ABUSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 16. U.S. DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 17. U.S. DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 18. U.S. DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 19. CANADA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 20. CANADA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 21. CANADA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 22. UK DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 23. UK DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 24. UK DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 25. GERMANY DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 26. GERMANY DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 27. GERMANY DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 28. ROE DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 29. ROE DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 30. ROE DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 31. CHINA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 32. CHINA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 33. CHINA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 34. INDIA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 35. INDIA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 36. INDIA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 37. JAPAN DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 38. JAPAN DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 39. JAPAN DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 40. ROAPAC DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 41. ROAPAC DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 42. ROAPAC DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 43. BRAZIL DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 44. BRAZIL DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 45. BRAZIL DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 46. MEXICO DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 47. MEXICO DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 48. MEXICO DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 49. ROLA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 50. ROLA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 51. ROLA DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 52. ROW DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 53. ROW DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 54. ROW DRUG ABUSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 55. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL DRUG ABUSE TESTING MARKET
TABLE 56. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL DRUG ABUSE TESTING MARKET
TABLE 57. YEARS CONSIDERED FOR THE STUDY
TABLE 58. EXCHANGE RATES CONSIDERED

LIST OF FIGURES

FIG 1. GLOBAL DRUG ABUSE TESTING MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL DRUG ABUSE TESTING MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL DRUG ABUSE TESTING MARKET, KEY TRENDS 2019
FIG 5. GLOBAL DRUG ABUSE TESTING MARKET, GROWTH PROSPECTS 2020-2027
FIG 6. GLOBAL DRUG ABUSE TESTING MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL DRUG ABUSE TESTING MARKET, PEST ANALYSIS
FIG 8. GLOBAL DRUG ABUSE TESTING MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL DRUG ABUSE TESTING MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 10. GLOBAL DRUG ABUSE TESTING MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 11. GLOBAL DRUG ABUSE TESTING MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 12. GLOBAL DRUG ABUSE TESTING MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 13. GLOBAL DRUG ABUSE TESTING MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 14. GLOBAL DRUG ABUSE TESTING MARKET, REGIONAL SNAPSHOT 2017 & 2027
FIG 15. NORTH AMERICA DRUG ABUSE TESTING MARKET 2017 & 2027 (USD BILLION)
FIG 16. EUROPE DRUG ABUSE TESTING MARKET 2017 & 2027 (USD BILLION)
FIG 17. ASIA PACIFIC DRUG ABUSE TESTING MARKET 2017 & 2027 (USD BILLION)
FIG 18. LATIN AMERICA DRUG ABUSE TESTING MARKET 2017 & 2027 (USD BILLION)
FIG 19. GLOBAL DRUG ABUSE TESTING MARKET, COMPANY MARKET SHARE ANALYSIS (2019)

















COMPANIES MENTIONED

Drдgerwerk AG & Co. KGaA
Abbott Laboratories
F. Hoffmann-La Roche AG
Bio-Rad Laboratories, Inc.
Siemens AG
Thermo Fisher Scientific, Inc.
Danaher Corporation
Quest Diagnostics Incorporated
Express Diagnostics International Inc.


More Publications